23andMe (ME) Scheduled to Post Quarterly Earnings on Thursday

23andMe (NASDAQ:MEGet Free Report) will be issuing its quarterly earnings data after the market closes on Thursday, May 23rd. Parties interested in registering for the company’s conference call can do so using this link.

23andMe Stock Down 3.0 %

Shares of NASDAQ ME opened at $0.53 on Wednesday. The firm has a market cap of $255.95 million, a price-to-earnings ratio of -0.48 and a beta of 1.24. 23andMe has a 52-week low of $0.35 and a 52-week high of $2.20. The business’s 50 day moving average is $0.49 and its two-hundred day moving average is $0.67.

Wall Street Analyst Weigh In

Separately, Citigroup cut their target price on 23andMe from $0.85 to $0.47 and set a “neutral” rating on the stock in a research report on Tuesday, April 16th.

Read Our Latest Report on 23andMe

23andMe Company Profile

(Get Free Report)

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.

Featured Stories

Earnings History for 23andMe (NASDAQ:ME)

Receive News & Ratings for 23andMe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 23andMe and related companies with MarketBeat.com's FREE daily email newsletter.